Regencell Bioscience Holdings Ltd (NYSE: RGC) — Healthcare · Share Price, Chart & Market Data
About: Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Latest price: $29.20 (+6.22%)
RGCRegencell Bioscience Holdings Ltd
Loading watchlist status…
Trade RGC now
Regencell Bioscience Holdings Ltd share price
RGC price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 5:49 pm GMT+0
RGC price performance
2.817%
5D
13.751%
1M
42.162%
YTD
3,131.217%
1Y
RGC price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NYSE rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 5:49 pm GMT+0
RGC details
RGC Market Signals